A detailed history of Sawgrass Asset Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sawgrass Asset Management LLC holds 90,927 shares of NBIX stock, worth $13.2 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
90,927
Previous 92,472 1.67%
Holding current value
$13.2 Million
Previous $12.8 Million 1.85%
% of portfolio
1.36%
Previous 1.41%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$130.86 - $143.19 $202,178 - $221,228
-1,545 Reduced 1.67%
90,927 $12.5 Million
Q1 2024

May 13, 2024

SELL
$130.4 - $143.74 $923,884 - $1.02 Million
-7,085 Reduced 7.12%
92,472 $12.8 Million
Q4 2023

Feb 06, 2024

BUY
$106.07 - $132.76 $10.6 Million - $13.2 Million
99,557 New
99,557 $13.1 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.